Equity Brief · Healthcare2026-05-20
SYK·Healthcare

Stryker Corporation

I · AI-analyse

In het kort

Stryker develops and sells medical devices for hospitals and doctors in two main segments: MedSurg/Neurotechnology (surgical tools, emergency equipment, stroke treatment devices, robotics) and Orthopaedics (hip/knee/shoulder implants, the Mako robotic surgery platform) [Yahoo Finance]. They operate in approximately 61 countries through their own sales teams and third-party distributors [Yahoo Finance].

Stryker Corporation is a $121.8 billion medical technology company that makes surgical equipment, robotic systems, and joint replacement implants sold to hospitals worldwide [Yahoo Finance]. The company reported strong revenue growth of +11.2% year-over-year to $25.1 billion, though recent news notes Q1 2026 earnings missed estimates due to a cyber incident [Yahoo Finance]. Financially, Stryker scores 10.0/10 for health with solid free cash flow of $4.3 billion, but the stock has dropped 21.4% over the past year [Yahoo Finance].

Stryker is financially robust with excellent margins, strong cash generation, and low leverage.

In het kort AI analysisBetrouwbaarheid 8/10

Sentinellis-score

10/10

Financially healthy

Marktkapitalisatie

$121.8B

Omzet (12 maanden)

$25.1B

II · Recent nieuws

Wat de koers bewoog

5 stories · ranked by relevance

  • macro2026-05-18

    PAHC or SYK: Which Is the Better Value Stock Right Now?

    Yahoo Finance

  • macro2026-05-19

    BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem

    Yahoo Finance

  • macro2026-05-16

    Is There Now An Opportunity In Stryker (SYK) After Recent Share Price Pullback

    Simply Wall St

  • macro2026-05-15

    Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating

    Yahoo Finance

  • macro2026-05-15

    Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom

    Yahoo Finance

Premium · gratis met elk account

Stryker trades at a PE ratio of 36.8x, which is elevated relative to historical norms and leaves the stock vulnerable to significant correction if earnings disappoint, especially with the next earnings report due July 30, 2026 [Yahoo Finance] [EODHD]

1 van 4 risico's in dit rapport

Risico's

4

Kansen

6

Waarschuwingssignalen

2

Leiding

10

Nog 21 bevindingen in het volledige rapport — gratis met elk account.

Ontgrendel de volledige analyse van Stryker Corporation

Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.

  • 4 risico's, 6 kansen en 2 waarschuwingssignalen — elk met zijn bron
  • Meer dan 100 financiële cijfers met grafieken en vergelijkingen
  • Volledige nieuwssamenvattingen met bronlinks
  • Directie en beloning
  • PDF-export voor offline
Ontgrendel alle 12 bevindingen3 gratis rapporten · geen creditcard

III · Vergelijkbare bedrijven

Misschien ook interessant

Same sector · Healthcare or comparable health

Op je volglijst zetten?

Read three companies free. Geen kaart.

Krijg 3 gratis rapporten